{"doi":"10.1016/j.bpg.2017.09.011","title":"Action and function of Faecalibacterium prausnitzii in health and disease","abstract":null,"journal":"Best Practice & Research Clinical Gastroenterology","year":2017,"id":612869,"datarank":0.9285473108779723,"base_score":6.1903154058531475,"endowment":6.1903154058531475,"self_citation_contribution":0.9285473108779723,"citation_network_contribution":0.0,"self_endowment_contribution":0.9285473108779723,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":487,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":25,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1578224,"name":"Alessandra Valéria de Sousa Faria","orcid":null,"position":1,"is_corresponding":false},{"id":1578225,"name":"Sheila Siqueira Andrade","orcid":null,"position":2,"is_corresponding":false},{"id":1578222,"name":"Carmen Veríssima Ferreira-Halder","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Action and function of Faecalibacterium prausnitzii in health and disease","abstract":"Faecalibacterium prausnitzii, anaerobic bacteria, is one of the main components of gut microbiota and the most important butyrate-producing bacteria in the human colon. So far, this commensal bacterium has been considered as a bioindicator of human health, once when its population is altered (decreased), inflammatory processes are favored. Several reports in the literature highlighted that the amount of Faecalibacterium prausnitzii negatively correlates to the activity of inflammatory bowel disease and colorectal cancer. Therefore, counterbalancing dysbiosis using Faecalibacterium prausnitzii as a potential active component of probiotic formulations appears to be a promising therapeutic strategy for inflammatory bowel diseases and colorectal cancer. However, once this microbial is very sensitive to oxygen, the formulation development is a great challenge. In this review, we will focus our attention on Faecalibacterium prausnitzii biology, anti-inflammatory metabolites, modulators of this bacterium population and its impact on human health.","is_dataset_classified":null,"base_score":6.1903154058531475,"endowment":6.1903154058531475,"datacite_reuse_total":25,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"29566907","pmcid":null,"openalex_id":"https://openalex.org/W2754184494","authors":[],"funders":[{"funder_name":"São Paulo Research Foundation","grant_id":"2015/20412-7","title":null},{"funder_name":"São Paulo Research Foundation","grant_id":"2016/14459-3","title":null}],"total_grants":2,"fwci":9.1235,"citation_percentile":0.98677311,"influential_citations":0,"citation_trend":[{"year":2018,"count":8},{"year":2019,"count":23},{"year":2020,"count":59},{"year":2021,"count":76},{"year":2022,"count":76},{"year":2023,"count":71},{"year":2024,"count":74},{"year":2025,"count":70},{"year":2026,"count":29}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S1521691817301063?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1521691817301063?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.bpg.2017.09.011","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/29566907","host_type":"repository"}],"fields_of_study":["Gut microbiota and health","Probiotics and Fermented Foods","Clostridium difficile and Clostridium perfringens research","Disease","Faecalibacterium prausnitzii","Gastrointestinal Microbiome","Humans"],"mesh_terms":["Gastrointestinal Microbiome","Faecalibacterium prausnitzii","Disease","Humans"],"keywords":["Faecalibacterium prausnitzii","Inflammatory bowel disease","Dysbiosis","Bifidobacterium","Population","Butyrate","Probiotic","Anaerobic bacteria","Colorectal cancer","Human microbiome","Medicine","Microbiology","Biology","Disease","Lactobacillus","Bacteria","Immunology","Gut flora","Cancer","Internal medicine","Environmental health","Food science","Anti-inflammatory","Platelets Function"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.14691964.v1","title":"Additional file 1 of Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14691964","title":"Additional file 1 of Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19593987.v1","title":"Additional file 1 of Gut bacteriobiota and mycobiota are both associated with Day-28 mortality among critically ill patients","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19593987","title":"Additional file 1 of Gut bacteriobiota and mycobiota are both associated with Day-28 mortality among critically ill patients","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22601318.v1","title":"Additional file 1 of Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22601318","title":"Additional file 1 of Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22735449.v1","title":"Additional file 1 of Location and condition based reconstruction of colon cancer microbiome from human RNA sequencing data","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22735449","title":"Additional file 1 of Location and condition based reconstruction of colon cancer microbiome from human RNA sequencing data","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25067277.v1","title":"Additional file 1 of Preliminary study of the effect of gut microbiota on the development of prostatitis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25067277","title":"Additional file 1 of Preliminary study of the effect of gut microbiota on the development of prostatitis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26605801.v1","title":"Additional file 1 of Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohort","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26605801","title":"Additional file 1 of Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohort","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26666473.v1","title":"Additional file 1 of Comparative analysis of metagenomic classifiers for long-read sequencing datasets","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26666473","title":"Additional file 1 of Comparative analysis of metagenomic classifiers for long-read sequencing datasets","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25067316.v1","title":"Additional file 2 of Preliminary study of the effect of gut microbiota on the development of prostatitis","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26672976.v1","title":"Additional file 3 of Preliminary study of the effect of gut microbiota on the development of prostatitis","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26672976","title":"Additional file 3 of Preliminary study of the effect of gut microbiota on the development of prostatitis","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.25067316","title":"Additional file 2 of Preliminary study of the effect of gut microbiota on the development of prostatitis","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26672979","title":"Additional file 4 of Preliminary study of the effect of gut microbiota on the development of prostatitis","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26672979.v1","title":"Additional file 4 of Preliminary study of the effect of gut microbiota on the development of prostatitis","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.23993388","title":"Additional file 3 of Dysbiosis of gut microbiota during fecal stream diversion in patients with colorectal cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.23993388.v1","title":"Additional file 3 of Dysbiosis of gut microbiota during fecal stream diversion in patients with colorectal cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.23993397","title":"Additional file 6 of Dysbiosis of gut microbiota during fecal stream diversion in patients with colorectal cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.23993391.v1","title":"Additional file 4 of Dysbiosis of gut microbiota during fecal stream diversion in patients with colorectal cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.23993394.v1","title":"Additional file 5 of Dysbiosis of gut microbiota during fecal stream diversion in patients with colorectal cancer","publisher":"figshare","resource_type":"Image"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-02T05:18:28.343925Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}